Page 1 | Search Results | Blood | American Society of Hematology

1-11 of 11

Sort by

Sort Order Select

Journal Articles

Benefits of a Pharmacist Led Oral Chemotherapy Monitoring Program for Patients with Chronic Myeloid Malignancies: A Patient Reported Outcome (PRO) Study

Jeffrey Baron, PharmD, Christina L. Lombardi, PharmD, Han Yu, PhD, Amanda Przespolewski, DO, Elizabeth A. Griffiths, MD, James E. Thompson, MD, Swapna Thota, MD, Eunice S. Wang, MD

Blood (2019) 134 (Supplement_1): 3501.

https://doi.org/10.1182/blood-2019-131629

Published: 2019

Journal Articles

Collaborative Physician-Pharmacist Managed Multiple Myeloma Clinic Decreases Polypharmacy, Improves Guideline Adherence, and Prevents Treatment Delays

Karen Sweiss, PharmD, Gregory Sampang Calip, PharmD, MPH, PhD, Scott Wirth, PharmD, Damiano Rondelli, MD, Pritesh Patel, MD

Blood (2018) 132 (Supplement 1): 3542.

https://doi.org/10.1182/blood-2018-99-117657

Published: 2018

Journal Articles

Positive Impact of Social Media on Disease Awareness and Management in Patients with Inherited Bleeding Disorders: Saudi Experience from a Tertiary Care Hospital

Mahsen AlSaleh, MD, Tarek Owaidah, MD, Hazzaa Alzahrani, MD, Tahani Bin Ali, MD, Huda ElFaraidi, MD, Mahmoud Abu Riash, RN, Zikra Alkhayal, MD, AbdulKareem Al Momen, MD, Viqaruddin Mohammed, MSc, CCRP, Azzah AlZahrani, MD

Blood (2017) 130 (Supplement 1): 5587.

https://doi.org/10.1182/blood.V130.Suppl_1.5587.5587

Published: 2017

Journal Articles

A Multidisciplinary Effort to Decrease Time from Admission to Chemotherapy on an Inpatient Oncology Unit

Louise Man, MD, Jeremy Sen, PharmD, BCOP, Jeanne Cahan, BSN, RN, Kathlene DeGregory, PharmD, BCOP, Tanya Thomas, BSN, RN, OCN, Elizabeth Daniels, RN, MSN, Erin McLoughlin, MD, Amy Morris, PharmD, Lisa Huntsinger, RN, MSN, CCRN, Michael Keng, MD

Blood (2017) 130 (Supplement 1): 2129.

https://doi.org/10.1182/blood.V130.Suppl_1.2129.2129

Published: 2017

Journal Articles

When Baking Soda Goes on Shortage

Germame Ajebo, MD, Locke J. Bryan, MD, Hoyle Whiteside, Arpita Gandhi

Blood (2017) 130 (Supplement 1): 4998.

https://doi.org/10.1182/blood.V130.Suppl_1.4998.4998

Published: 2017

Journal Articles

The Importance of Pharmacovigilance during Ibrutinib Therapy for Chronic Lymphocytic Leukemia (CLL) in Routine Clinical Practice

Heidi D. Finnes, PharmD, Kari G. Chaffee, MS, Timothy G. Call, MD, Wei Ding, MD PhD, Deborah A. Bowen, APRN, CNP, Michael Conte, PA-C, Kristen B. McCullough, PharmD, Julianna A. Merten, PharmD, Gabriel T. Bartoo, PharmD, Matthew D. Smith, PharmD, Susan M. Schwager, Susan L. Slager, PhD, Neil E. Kay, MD, Tait D. Shanafelt, MD, Sameer A. Parikh, MD

Blood (2015) 126 (23): 717.

https://doi.org/10.1182/blood.V126.23.717.717

Published: 2015

Journal Articles

Acquired Hemophilia Network;non Hematologist Perspectives

Ahmed F Mady, MDS-FCCM,FCCP, Basim R Huwait, MRCP,EDIC,S-FCCM, Muhammad Asim Rana, MRCP,EDIC,S-FCCM,FCCP, Omar E Ramadan, MDS-FCCM, Abulrahman Al-Harthy, MDS-FCCM, Abdul Kareem M Al-Momen, MD FRCPC

Blood (2014) 124 (21): 5978.

https://doi.org/10.1182/blood.V124.21.5978.5978

Published: 2014

Journal Articles

Appropriateness Of Prescribing Of Direct Oral Anticoagulants: A Prospective Cohort Study At CHU UCL Mont-Godinne-Dinant

Anne-Sophie Larock, PharmD, François Mullier, Professor, Jonathan Douxfils, PhD, Jean-Michel Dogné, Christian Chatelain, Anne Spinewine

Blood (2013) 122 (21): 4809.

https://doi.org/10.1182/blood.V122.21.4809.4809

Published: 2013

Journal Articles

Improving Rates of Appropriate Venous Thromboembolism Prophylaxis in a Community Hospital.

Danette Beechinor, BSc Pharm, Pharm D

Blood (2012) 120 (21): 3159.

https://doi.org/10.1182/blood.V120.21.3159.3159

Published: 2012

Journal Articles

Drug-Drug Interactions in the Hematology and Oncology Department: A Real-Life Assessment of Frequency and Severity

Barbara Metzke, Martin J Hug, PhD, Geertje Fink, MD, Stefanie Hieke, Manfred Jung, PhD, Monika Engelhardt

Blood (2012) 120 (21): 4250.

https://doi.org/10.1182/blood.V120.21.4250.4250

Published: 2012

Journal Articles

Experience with the “Off Label” Use of Recombinant Factor VIIa in a University Hospital.

Miguel A. Escobar, MD, Kenneth Chong, Pharm D, Keith W. Hoots, MD

Blood (2004) 104 (11): 4017.

https://doi.org/10.1182/blood.V104.11.4017.4017

Published: 2004

NARROW

Benefits of a Pharmacist Led Oral Chemotherapy Monitoring Program for Patients with Chronic Myeloid Malignancies: A Patient Reported Outcome (PRO) Study

Collaborative Physician-Pharmacist Managed Multiple Myeloma Clinic Decreases Polypharmacy, Improves Guideline Adherence, and Prevents Treatment Delays

Positive Impact of Social Media on Disease Awareness and Management in Patients with Inherited Bleeding Disorders: Saudi Experience from a Tertiary Care Hospital

A Multidisciplinary Effort to Decrease Time from Admission to Chemotherapy on an Inpatient Oncology Unit

When Baking Soda Goes on Shortage

The Importance of Pharmacovigilance during Ibrutinib Therapy for Chronic Lymphocytic Leukemia (CLL) in Routine Clinical Practice

Acquired Hemophilia Network;non Hematologist Perspectives

Appropriateness Of Prescribing Of Direct Oral Anticoagulants: A Prospective Cohort Study At CHU UCL Mont-Godinne-Dinant

Improving Rates of Appropriate Venous Thromboembolism Prophylaxis in a Community Hospital.

Drug-Drug Interactions in the Hematology and Oncology Department: A Real-Life Assessment of Frequency and Severity

Experience with the “Off Label” Use of Recombinant Factor VIIa in a University Hospital.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only